Evidence Level Hierarchy
Peptide research follows a clear evidence hierarchy from initial laboratory studies to approved therapies. Understanding these levels helps evaluate research quality and reliability.
Preclinical Studies
Preclinical research includes in vitro (cell culture) and animal studies. Peptides like BPC-157 have extensive preclinical evidence but limited human data. These studies establish basic safety and mechanisms but don't guarantee human efficacy.
Phase 1-3 Clinical Trials
Phase 1 tests basic human safety in small groups. Phase 2 evaluates efficacy in larger populations with the target condition. Phase 3 compares against standard treatments in hundreds of subjects. AOD-9604 reached Phase 2 trials for obesity research.
Approved Therapies
FDA-approved peptides like gonadorelin have completed all trial phases and demonstrated safety and efficacy. However, approval for one indication doesn't validate off-label research uses.
Evaluating Evidence Quality
Higher evidence levels don't automatically mean better research outcomes. A well-designed preclinical study may provide more reliable data than a poorly controlled human trial. Consider sample sizes, controls, and methodology quality.
Research Applications
When reviewing peptide research, start with the highest available evidence level for your specific research question. Don't dismiss lower-level evidence, but understand its limitations.
This information is for research purposes only and does not constitute medical advice. Always evaluate evidence quality independent of hierarchy level.